LONGER-TERM SAFETY and EFFICACY of OFATUMUMAB in PEOPLE with RELAPSING MULTIPLE SCLEROSIS for UP to 6 YEARS

Authors
Category Primary study
Conference54th Annual Conference of the Italian Society of Neurology
Year 2024
This article has no abstract
Epistemonikos ID: 3c786bd2f22622c1cd9699d159fba2a8edbbaf3d
First added on: Jan 10, 2026